摘要
目的系统评价轻度认知障碍(MCI)进展为阿尔兹海默症(AD)的风险因素,为早期干预提供参考依据。方法计算机检索国内外6大数据库有关MCI患者进展为AD影响因素的文献,检索时间从建库至2022年12月,由2名研究者单独进行文献筛选及数据提取,采用Stata SE12.0软件进行数据分析。结果最终纳入文献35篇,共10985例MCI患者,提取风险因素13个。Meta分析结果显示:MCI患者AD的患病率为32%,其中年龄(RR=1.07,95%CI:1.02~1.13)、性别(RR=1.50,95%CI:1.33~1.68)、抑郁(RR=1.23,95%CI:1.02~1.48)、高血压(RR=1.45,95%CI:1.04~2.03)、糖尿病(RR=1.92,95%CI:1.44~2.56)、脑血管疾病(RR=1.78,95%CI:1.18~2.69)、携带ApoE基因(RR=1.77,95%CI:1.56~2.01)是MCI进展为AD的危险因素(P<0.05)。结论MCI患者转化为AD的风险较高,且影响因素较多,应早期进行筛查与干预,以降低AD的发生率。
Objective To systematically evaluate risk factors for the progression of mild cognitive impairment(MCI)to Alzheimer’s disease(AD)so as to provide a reference for early intervention.Methods A computerized search for the literature on risk factors influencing the progression of MCI patients to AD was conducted in 6 major domestic and international databases,and the retrieval time was from the establishment of the database to December 2022.Literature screening and data extraction were performed by 2 researchers individually,and data were analyzed using Stata SE12.0 software.Results A total of 35 articles were included,comprising 10,985 MCI patients,with 13 identified risk factors.Meta-analysis results indicated that the prevalence of AD in MCI patients was 32%,with age[RR=1.07,95%CI(1.02-1.13)],gender[RR=1.50,95%CI(1.33-1.68)],depression[RR=1.23,95%CI(1.02-1.48)],hypertension[RR=1.45,95%CI(1.04-2.03)],diabetes[RR=1.92,95%CI(1.44-2.56)],cerebrovascular disease[RR=1.78,95%CI(1.18-2.69)],and the ApoE gene[RR=1.77,95%CI(1.56-2.01)]identified as significant risk factors for the progression of MCI to AD(P<0.05).Conclusions MCI patients have a relatively high risk of the progression of MCI to AD,and there are different risk factors.Early screening and intervention should be advisably carried out to reduce the incidence of AD.
作者
喻思思
罗拯
钟清玲
YU Si-si;LUO Zheng;ZHONG Qing-ling(School of Nursing,Jiangxi University of Traditional Chinese Medicine,Nanchang 330004,China;Department of Neurology,the First Affiliated Hospital of Nanchang University,Nanchang 330004,China;School of Nursing of Nanchang University,Nanchang 330004,China)
出处
《实用临床医学(江西)》
CAS
2024年第4期80-88,共9页
Practical Clinical Medicine
基金
江西省教育厅科学技术研究项目(GJJ2200970)
江西省中医药管理局科技计划项目(2023B0008)。